131 related articles for article (PubMed ID: 3631886)
1. Antitumor activity and toxicity in mice of RA-700, a cyclic hexapeptide.
Kato T; Suzumura Y; Takamoto S; Ota K
Anticancer Res; 1987; 7(3 Pt B):329-34. PubMed ID: 3631886
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of antitumor activity of vincristine by the biscoclaurine alkaloid cepharanthine.
Kato T; Suzumura Y
J Natl Cancer Inst; 1987 Sep; 79(3):527-32. PubMed ID: 3476792
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
Bernacki RJ; Wilson GL; Mossman BT; Angelino N; Kanter PM; Korytnyk W
Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170
[TBL] [Abstract][Full Text] [Related]
4. Induced resistance in leukaemia L1210 to adriamycin and its cross-resistance to vincristine and bouvardin.
Chitnis MP; Joshi SS; Gude RP; Menon RS
Chemotherapy; 1982; 28(3):209-12. PubMed ID: 7094661
[TBL] [Abstract][Full Text] [Related]
5. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
Tsuruo T; Iida H; Kitatani Y; Yokota K; Tsukagoshi S; Sakurai Y
Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192
[TBL] [Abstract][Full Text] [Related]
6. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of novel ailanthone derivatives in vitro and in vivo.
Kato T; Suzumura Y; Fukushima M; Honda T; Nakanishi T; Noguchi T
Anticancer Res; 1988; 8(4):573-9. PubMed ID: 3178149
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
[TBL] [Abstract][Full Text] [Related]
9. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
[TBL] [Abstract][Full Text] [Related]
10. Uptake, initial effects, and chemotherapeutic efficacy of harringtonine in murine leukemic cells sensitive and resistant to vincristine and other chemotherapeutic agents.
Chou TC; Schmid FA; Feinberg A; Philips FS; Han J
Cancer Res; 1983 Jul; 43(7):3074-9. PubMed ID: 6189591
[TBL] [Abstract][Full Text] [Related]
11. Modification of tumor cell sensitivity to antineoplastic agents lonidamine and bouvardin (NSC 259968) at elevated temperatures.
Adwankar MK; Chitnis MP
Neoplasma; 1986; 33(2):217-23. PubMed ID: 3713924
[TBL] [Abstract][Full Text] [Related]
12. In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52.
Shinoda H; Inaba M; Tsuruo T
Cancer Res; 1989 Apr; 49(7):1722-6. PubMed ID: 2924316
[TBL] [Abstract][Full Text] [Related]
13. Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors.
Mayer LD; Bally MB; Loughrey H; Masin D; Cullis PR
Cancer Res; 1990 Feb; 50(3):575-9. PubMed ID: 2297698
[TBL] [Abstract][Full Text] [Related]
14. [Antitumor effect of 1,3,3,5,5-pentaziridino-1-thia-2,4,6-triaza-3,5- diphoshorine-1-oxide].
Kato T; Takamoto S; Ota K
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3401-7. PubMed ID: 3789752
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
Guo QL; Wu MS; Chen Z
Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
Li LH; Wallace TL; Richard KA; Tracey DE
Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity.
McRipley RJ; Burns-Horwitz PE; Czerniak PM; Diamond RJ; Diamond MA; Miller JL; Page RJ; Dexter DL; Chen SF; Sun JH
Cancer Res; 1994 Jan; 54(1):159-64. PubMed ID: 8261436
[TBL] [Abstract][Full Text] [Related]
18. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
[TBL] [Abstract][Full Text] [Related]
19. Action of free radical in podophyllic acid piperindyl hydrazone nitroxide radical on its antitumor activity and toxicity.
Jia ZP; Wang R; Xie JW; Xu LT
Zhongguo Yao Li Xue Bao; 1999 Jun; 20(6):571-6. PubMed ID: 10678157
[TBL] [Abstract][Full Text] [Related]
20. Experimental antitumor activity of new azathioprine analogues.
Hładoń B; Gutsche W; Bałoniak S; Sikorska H
Arzneimittelforschung; 1989 Jan; 39(1):78-81. PubMed ID: 2719747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
